New treatment tested for Tough-to-Treat colon cancer
Disease control
Recruiting now
This study is testing two different dosing schedules of an experimental drug called EMB-01 for people with advanced colorectal cancer that has returned or spread after previous treatments. About 54 participants will be randomly assigned to receive weekly injections or a schedule …
Phase: PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC